Project Grant K01HL181305
- This Project Grant award of $549,128 from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a study to investigate the relationship between early-life factors, telomere length, and the development of subclinical atherosclerosis. The research team at The Research Foundation For The State University Of New York (RF SUNY) will measure telomere length from birth to young adulthood and assess its association with growth, air pollution exposure, and...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $705,279 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to Trustees of Boston University, doing business as Boston University Medical Campus, to investigate the mechanisms by which environmental pollutants impact the cardiovascular system. The 4-year project, starting January 1, 2025, will use a multidisciplinary approach including physiological studies, cellular imaging, RNA-sequencing, and mouse models to...
- This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support a study examining the link between stressful life events and cardiovascular disease (CVD) risk. The $156,858 award, granted on February 1, 2025, will enable the University of Pittsburgh to utilize deidentified data from 656 healthy adults to investigate how brain and behavioral measures of negative affect and cognitive reappraisal...
- This $781,268 Project Grant awarded by the National Institute of Environmental Health Sciences (CFDA 93.113 Environmental Health) will fund research at the University of Southern California to investigate the cardiovascular health impacts of environmental exposures to heat stress and wildfire smoke over the life course. The 5-year study, running from June 2025 to April 2030, will leverage the MetaAIR2 cohort of 400 young adults to examine how these exposures, both independently and jointly,...
- This federal Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) in the amount of $293,395 provides funding to the University of Connecticut Health Center to conduct research on democratizing access to effective air purification devices to reduce particulate air pollution (PM2.5) exposure and prevent adverse health outcomes. The project involves three main activities: 1) conducting focus groups and interviews to refine the...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Rutgers, The State University of New Jersey is for a study titled "Psychosocial and Cultural Determinants of Cardiometabolic Health Among Older Chinese Americans". The $721,720 study aims to investigate how psychosocial stress and sociocultural factors affect cardiometabolic health in older foreign-born Chinese Americans over a 4-year period. Key focus areas...
- The National Heart, Lung, and Blood Institute awarded a $156,486 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Denver. The 5-year grant, running from July 2, 2025 to January 5, 2027, will support research examining the association between discrimination reported during pregnancy and cardiovascular disease risk in mothers 3-4 years postpartum. The study will use a prospective longitudinal design with a population of at least 200...
- This $254,250 project grant from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to advance understanding of the relationship between neighborhood factors and sleep health disparities among first and second grade students, primarily Black children, living in urban New York City neighborhoods. The study will merge a comprehensive public dataset on neighborhood characteristics (Child Opportunity Index 3.0) with a longitudinal dataset from a...
- This federal Project Grant award, provided by the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), will fund research to investigate place-based factors contributing to sleep health disparities in the United States. The $177,385 award to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System, will: 1) Estimate sleep health measures and environmental circadian misalignment across different populations and geographies; 2) Examine...
- This Project Grant award of $609,850 from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) will fund a longitudinal study to examine food insecurity as a social determinant of cardiovascular health in a marginalized immigrant Latino population. The study will collect mixed-methods data from 450 Latino immigrants to characterize patterns of food insecurity over time and how it, along with trauma, impacts cardiovascular disease risk and psychological...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to study the effects of structural racism on disparities in environmental exposures and cardiovascular disease (CVD) outcomes. The $123,368 award to The Research Foundation For The State University Of New York (UEI LVVEB3CF8MB8), effective September 16, 2025 through August 31, 2030, will leverage New York's all-payer hospital database and integrate it with primary data collection to disentangle the impacts of combined environmental and social burdens on CVDs associated with historical redlining. The project will train the principal investigator in advanced statistical methods, real-time data collection, co-exposure analysis, and implementation science to identify potential risk and susceptibility indicators and evaluate the independent and combined effects of neighborhood social and environmental factors on CVD outcomes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $123.4k | 9/16/25 |